Janet A Deatrick1, Anne E Kazak2,3, Rebecca E Madden4, Glynnis A McDonnell5, Katherine Okonak5, Michele A Scialla5, Lamia P Barakat4,6. 1. Department of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, USA. 2. ABPP Center for Healthcare Delivery Science, Nemours Pediatric Healthcare System, Rockland Center One, 1701 Rockland Road, Wilmington, USA. anne.kazak@nemours.org. 3. Department of Pediatrics, Sidney Kimmel Medical School of Thomas Jefferson University, Philadelphia, USA. anne.kazak@nemours.org. 4. Divison of Oncology, The Children's Hospital of Philadelphia, Philadelphia, USA. 5. ABPP Center for Healthcare Delivery Science, Nemours Pediatric Healthcare System, Rockland Center One, 1701 Rockland Road, Wilmington, USA. 6. Department of Pediatrics, Perelman/School of Medicine of the University of Pennsylvania, Philadelphia, USA.
Abstract
BACKGROUND: Children with cancer and their families are at risk for short- and long-term psychosocial difficulties. Screening for psychosocial risk remains inconsistent, leading to inequitable access to psychosocial services. The Psychosocial Assessment Tool (PAT) is an evidence-based caregiver report screener of family psychosocial risk ready for implementation in a nationwide cluster randomized trial that will test two implementation strategies across 18 pediatric cancer centers. The current study, conducted in preparation for the trial, solicited the perspectives of key stakeholders about two proposed implementation strategies identified during previous research which focus on health equity and screening of all families (universal screening). Results were used to refine the implementation strategies for testing in the subsequent trial. METHODS: Semi-structured interviews with 19 key stakeholders (parents, health care providers, pediatric oncology organizations, and pediatric healthcare leaders) were conducted regarding the two implementation strategies. Strategy I is a training webinar; Strategy II is training + implementation enhanced resources, which includes a champion at each site and monthly peer support consultation calls. Data were analyzed using directed content analysis with deductively derived codes based on the Interactive Systems Framework and inductive codes based on emerging data. RESULTS: Stakeholder interviews provided rich data to rigorously modify the proposed implementation strategies. Implementation strategies were modified in consistent with these recommendations: engaging providers by framing family psychosocial screening as an opportunity for more efficient and effective practice; setting clear expectations about the importance of screening 100% of children and their families to achieve the goal of universal screening, equity of care, and reduction of disparities; and adapting successful strategies for systematic implementation of screening to ensure optimal engagement with children and their families throughout their care. CONCLUSIONS: Stakeholder input strengthened implementation strategies by suggesting modifications that emphasized health equity and reduction in health disparities. Using implementation science methods to build on a long-standing program of research provided practical insights about immediate needs of families and historical insights regarding structural inequities such as language differences and access to services. Resulting strategies address all levels of the social ecology for children's cancer care, including the patient, family, provider, healthcare system, and community. TRIAL REGISTRATION: NCT04446728 June 23, 2020.
BACKGROUND:Children with cancer and their families are at risk for short- and long-term psychosocial difficulties. Screening for psychosocial risk remains inconsistent, leading to inequitable access to psychosocial services. The Psychosocial Assessment Tool (PAT) is an evidence-based caregiver report screener of family psychosocial risk ready for implementation in a nationwide cluster randomized trial that will test two implementation strategies across 18 pediatric cancer centers. The current study, conducted in preparation for the trial, solicited the perspectives of key stakeholders about two proposed implementation strategies identified during previous research which focus on health equity and screening of all families (universal screening). Results were used to refine the implementation strategies for testing in the subsequent trial. METHODS: Semi-structured interviews with 19 key stakeholders (parents, health care providers, pediatric oncology organizations, and pediatric healthcare leaders) were conducted regarding the two implementation strategies. Strategy I is a training webinar; Strategy II is training + implementation enhanced resources, which includes a champion at each site and monthly peer support consultation calls. Data were analyzed using directed content analysis with deductively derived codes based on the Interactive Systems Framework and inductive codes based on emerging data. RESULTS: Stakeholder interviews provided rich data to rigorously modify the proposed implementation strategies. Implementation strategies were modified in consistent with these recommendations: engaging providers by framing family psychosocial screening as an opportunity for more efficient and effective practice; setting clear expectations about the importance of screening 100% of children and their families to achieve the goal of universal screening, equity of care, and reduction of disparities; and adapting successful strategies for systematic implementation of screening to ensure optimal engagement with children and their families throughout their care. CONCLUSIONS: Stakeholder input strengthened implementation strategies by suggesting modifications that emphasized health equity and reduction in health disparities. Using implementation science methods to build on a long-standing program of research provided practical insights about immediate needs of families and historical insights regarding structural inequities such as language differences and access to services. Resulting strategies address all levels of the social ecology for children's cancer care, including the patient, family, provider, healthcare system, and community. TRIAL REGISTRATION: NCT04446728 June 23, 2020.
Authors: Abraham Wandersman; Jennifer Duffy; Paul Flaspohler; Rita Noonan; Keri Lubell; Lindsey Stillman; Morris Blachman; Richard Dunville; Janet Saul Journal: Am J Community Psychol Date: 2008-06
Authors: Anne E Kazak; Lamia P Barakat; Wei-Ting Hwang; Susan Ditaranto; Daniel Biros; David Beele; Leslie Kersun; Matthew C Hocking; Anne Reilly Journal: Psychooncology Date: 2011-04-07 Impact factor: 3.894
Authors: Lori Wiener; Anne E Kazak; Robert B Noll; Andrea Farkas Patenaude; Mary Jo Kupst Journal: Pediatr Blood Cancer Date: 2015-09-23 Impact factor: 3.167
Authors: Anne E Kazak; Wei-Ting Hwang; Fang Fang Chen; Martha A Askins; Olivia Carlson; Francisco Argueta-Ortiz; Lamia P Barakat Journal: J Pediatr Psychol Date: 2018-08-01
Authors: Anne E Kazak; Annah N Abrams; Jaime Banks; Jennifer Christofferson; Stephen DiDonato; Martha A Grootenhuis; Marianne Kabour; Avi Madan-Swain; Sunita K Patel; Sima Zadeh; Mary Jo Kupst Journal: Pediatr Blood Cancer Date: 2015-12 Impact factor: 3.167
Authors: Anne E Kazak; Janet A Deatrick; Michele A Scialla; Eric Sandler; Rebecca E Madden; Lamia P Barakat Journal: Implement Sci Date: 2020-07-29 Impact factor: 7.327
Authors: Teaniese L Davis; Willemijn L A Schäfer; Sarah C Blake; Sharron Close; Salva N Balbale; Joseph E Perry; Raul Perez Zarate; Martha Ingram; Jennifer Strople; Julie K Johnson; Jane L Holl; Mehul V Raval Journal: Implement Sci Commun Date: 2022-08-18